T18	B-Entity	0	8	Membrane	Membrane	B-NP	NN	B-protein	4	NMOD	B-protein
T18	I-Entity	8	9	-	-	B-PP	HYPH	I-protein	4	NMOD	I-protein
T18	I-Entity	9	19	associated	associate	B-NP	VBN	I-protein	4	NMOD	I-protein
T18	I-Entity	20	31	lymphotoxin	lymphotoxin	I-NP	NN	I-protein	9	SUB	I-protein
O	O	32	34	on	on	B-PP	IN	O	4	NMOD	O
O	O	35	42	natural	natural	B-NP	JJ	B-cell_type	8	NMOD	B-cell_type
O	O	43	49	killer	killer	I-NP	NN	I-cell_type	8	NMOD	I-cell_type
O	O	50	55	cells	cell	I-NP	NNS	I-cell_type	5	PMOD	I-cell_type
O	O	56	65	activates	activate	B-VP	VBZ	O	0	ROOT	O
O	O	66	77	endothelial	endothelial	B-NP	JJ	B-cell_type	11	NMOD	B-cell_type
O	O	78	83	cells	cell	I-NP	NNS	I-cell_type	9	OBJ	I-cell_type
O	O	84	87	via	via	B-PP	IN	O	9	VMOD	O
O	O	88	90	an	an	B-NP	DT	O	19	NMOD	O
T19	B-Entity	91	93	NF	NF	I-NP	NN	B-protein	16	NMOD	B-protein
T19	I-Entity	93	94	-	-	I-NP	HYPH	I-protein	16	P	I-protein
T19	I-Entity	94	100	kappaB	kappaB	I-NP	NN	I-protein	19	NMOD	I-protein
O	O	100	101	-	-	I-NP	HYPH	O	19	NMOD	O
O	O	101	110	dependent	dependent	I-NP	JJ	O	19	NMOD	O
O	O	111	118	pathway	pathway	I-NP	NN	O	12	PMOD	O
O	O	118	119	.	.	O	.	O	9	P	O

O	O	121	131	BACKGROUND	BACKGROUND	B-NP	NN	O	0	ROOT	O
O	O	131	132	:	:	O	:	O	1	P	O
O	O	133	143	Inhibition	Inhibition	B-NP	NN	O	12	SUB	O
O	O	144	146	of	of	B-PP	IN	O	3	NMOD	O
O	O	147	157	complement	complement	B-NP	NN	O	4	PMOD	O
O	O	158	160	in	in	B-PP	IN	O	3	NMOD	O
O	O	161	166	small	small	B-NP	JJ	O	9	NMOD	O
O	O	167	173	animal	animal	I-NP	NN	O	9	NMOD	O
O	O	174	180	models	model	I-NP	NNS	O	6	PMOD	O
O	O	181	183	of	of	B-PP	IN	O	9	NMOD	O
O	O	184	203	xenotransplantation	xenotransplantation	B-NP	NN	O	10	PMOD	O
O	O	204	207	has	have	B-VP	VBZ	O	1	NMOD	O
O	O	208	220	demonstrated	demonstrate	I-VP	VBN	O	12	VC	O
O	O	221	226	graft	graft	B-NP	NN	O	15	NMOD	O
O	O	227	239	infiltration	infiltration	I-NP	NN	O	13	OBJ	O
O	O	240	244	with	with	B-PP	IN	O	15	NMOD	O
O	O	245	252	natural	natural	B-NP	JJ	B-cell_type	22	NMOD	B-cell_type
O	O	253	259	killer	killer	I-NP	NN	I-cell_type	22	NMOD	I-cell_type
O	O	260	261	(	(	O	(	I-cell_type	21	DEP	I-cell_type
O	O	261	263	NK	NK	B-NP	NN	I-cell_type	21	DEP	I-cell_type
O	O	263	264	)	)	O	)	I-cell_type	22	NMOD	I-cell_type
O	O	265	270	cells	cell	B-NP	NNS	I-cell_type	24	NMOD	I-cell_type
O	O	271	274	and	and	I-NP	CC	O	24	NMOD	O
O	O	275	284	monocytes	monocyte	I-NP	NNS	B-cell_type	16	PMOD	B-cell_type
O	O	285	295	associated	associate	B-VP	VBN	O	24	NMOD	O
O	O	296	300	with	with	B-PP	IN	O	25	VMOD	O
O	O	301	312	endothelial	endothelial	B-NP	JJ	B-cell_type	28	NMOD	B-cell_type
O	O	313	317	cell	cell	I-NP	NN	I-cell_type	32	NMOD	I-cell_type
O	O	318	319	(	(	O	(	O	31	DEP	O
O	O	319	321	EC	EC	B-NP	NN	B-cell_type	31	DEP	B-cell_type
O	O	321	322	)	)	O	)	O	28	NMOD	O
O	O	323	333	activation	activation	B-NP	NN	O	26	PMOD	O
O	O	333	334	.	.	O	.	O	12	P	O

O	O	335	337	We	We	B-NP	PRP	O	2	SUB	O
O	O	338	342	have	have	B-VP	VBP	O	0	ROOT	O
O	O	343	353	previously	previously	I-VP	RB	O	2	VMOD	O
O	O	354	366	demonstrated	demonstrate	I-VP	VBN	O	2	VC	O
O	O	367	371	that	that	B-SBAR	IN	O	4	VMOD	O
O	O	372	377	human	human	B-NP	JJ	B-cell_type	8	NMOD	B-cell_type
O	O	378	380	NK	NK	I-NP	NN	I-cell_type	8	NMOD	I-cell_type
O	O	381	386	cells	cell	I-NP	NNS	I-cell_type	9	SUB	I-cell_type
O	O	387	395	activate	activate	B-VP	VBP	O	5	SBAR	O
O	O	396	403	porcine	porcine	B-NP	JJ	O	11	NMOD	O
O	O	404	406	EC	EC	I-NP	NN	B-cell_type	9	OBJ	B-cell_type
O	O	407	409	in	in	B-ADVP	FW	O	9	VMOD	O
O	O	410	415	vitro	vitro	I-ADVP	FW	O	12	AMOD	O
O	O	415	416	,	,	O	,	O	9	P	O
O	O	417	422	which	which	B-NP	WDT	O	9	VMOD	O
O	O	423	430	results	result	B-VP	VBZ	O	15	SBAR	O
O	O	431	433	in	in	B-PP	IN	O	16	VMOD	O
O	O	434	442	adhesion	adhesion	B-NP	NN	B-protein	20	NMOD	B-protein
O	O	443	451	molecule	molecule	I-NP	NN	I-protein	20	NMOD	I-protein
O	O	452	462	expression	expression	I-NP	NN	O	23	NMOD	O
O	O	463	466	and	and	O	CC	O	23	NMOD	O
O	O	467	475	cytokine	cytokine	B-NP	NN	B-protein	23	NMOD	B-protein
O	O	476	485	secretion	secretion	I-NP	NN	O	17	PMOD	O
O	O	485	486	.	.	O	.	O	2	P	O

O	O	487	489	In	In	B-PP	IN	O	6	VMOD	O
O	O	490	494	this	this	B-NP	DT	O	3	NMOD	O
O	O	495	500	study	study	I-NP	NN	O	1	PMOD	O
O	O	500	501	,	,	O	,	O	6	P	O
O	O	502	504	we	we	B-NP	PRP	O	6	SUB	O
O	O	505	509	used	use	B-VP	VBD	O	0	ROOT	O
O	O	510	513	the	the	B-NP	DT	O	11	NMOD	O
O	O	514	516	NK	NK	I-NP	NN	B-cell_line	11	NMOD	B-cell_line
O	O	517	521	cell	cell	I-NP	NN	I-cell_line	11	NMOD	I-cell_line
O	O	522	526	line	line	I-NP	NN	I-cell_line	11	NMOD	I-cell_line
O	O	527	531	NK92	NK92	I-NP	NN	I-cell_line	6	OBJ	I-cell_line
O	O	532	534	to	to	B-VP	TO	O	13	VMOD	O
O	O	535	541	define	define	I-VP	VB	O	6	VMOD	O
O	O	542	545	the	the	B-NP	DT	O	18	NMOD	O
O	O	546	555	molecular	molecular	I-NP	JJ	O	17	AMOD	O
O	O	556	559	and	and	I-NP	CC	O	17	AMOD	O
O	O	560	568	cellular	cellular	I-NP	JJ	O	18	NMOD	O
O	O	569	574	basis	basis	I-NP	NN	O	13	OBJ	O
O	O	575	577	of	of	B-PP	IN	O	18	NMOD	O
O	O	578	580	NK	NK	B-NP	NN	B-cell_type	21	NMOD	B-cell_type
O	O	581	585	cell	cell	I-NP	NN	I-cell_type	25	NMOD	I-cell_type
O	O	585	586	-	-	B-NP	HYPH	O	25	NMOD	O
O	O	586	594	mediated	mediate	I-NP	VBN	O	25	NMOD	O
O	O	595	597	EC	EC	I-NP	NN	B-cell_type	25	NMOD	B-cell_type
O	O	598	608	activation	activation	I-NP	NN	O	19	PMOD	O
O	O	608	609	.	.	O	.	O	6	P	O

O	O	610	617	METHODS	METHODS	B-NP	NNS	O	0	ROOT	O
O	O	617	618	:	:	O	:	O	1	P	O
O	O	619	621	EC	EC	B-NP	NNS	B-cell_type	4	SUB	B-cell_type
O	O	622	626	were	be	B-VP	VBD	O	1	NMOD	O
O	O	627	638	transfected	transfecte	I-VP	VBN	O	4	VC	O
O	O	639	643	with	with	B-PP	IN	O	5	VMOD	O
O	O	644	650	either	either	O	CC	O	6	PMOD	O
O	O	651	659	reporter	reporter	B-NP	NN	B-DNA	9	NMOD	B-DNA
O	O	660	670	constructs	construct	I-NP	NNS	I-DNA	7	OBJ	I-DNA
O	O	671	681	containing	contain	B-VP	VBG	O	9	NMOD	O
O	O	682	685	the	the	B-NP	DT	O	13	NMOD	O
T20	B-Entity	686	696	luciferase	luciferase	I-NP	NN	B-DNA	13	NMOD	B-DNA
T20	I-Entity	697	701	gene	gene	I-NP	NN	I-DNA	10	OBJ	I-DNA
O	O	702	708	driven	drive	B-VP	VBN	O	13	NMOD	O
O	O	709	715	either	either	B-PP	CC	O	16	PMOD	O
O	O	716	718	by	by	I-PP	IN	O	13	NMOD	O
T1	B-Protein	719	720	E	E	B-NP	NN	B-protein	19	NMOD	B-protein
T1	I-Protein	720	721	-	-	I-NP	HYPH	I-protein	19	NMOD	I-protein
T1	I-Protein	721	729	selectin	selectin	I-NP	NN	I-protein	23	NMOD	I-protein
O	O	730	732	or	or	I-NP	CC	O	23	NMOD	O
T2	B-Protein	733	744	interleukin	interleukin	I-NP	NN	B-DNA	23	NMOD	B-DNA
T2	I-Protein	745	746	(	(	O	(	I-DNA	23	NMOD	I-DNA
T2	I-Protein	746	748	IL	IL	B-NP	NN	I-DNA	27	NMOD	I-DNA
T2	I-Protein	748	749	)	)	O	)	I-DNA	23	NMOD	I-DNA
T2	I-Protein	749	750	-	-	O	HYPH	I-DNA	23	NMOD	I-DNA
T2	I-Protein	750	751	8	8	B-NP	CD	I-DNA	23	NMOD	I-DNA
T21	B-Entity	752	761	promoters	promoter	I-NP	NNS	I-DNA	30	NMOD	I-DNA
O	O	762	764	or	or	O	CC	O	30	NMOD	O
O	O	765	766	a	a	B-NP	DT	O	30	NMOD	O
O	O	767	776	synthetic	synthetic	I-NP	JJ	O	35	AMOD	O
T22,T23	B-Entity,B-Entity	777	779	NF	NF	I-NP	NN	B-protein	33	NMOD	B-protein
T22,T23	I-Entity,I-Entity	779	780	-	-	B-NP	HYPH	I-protein	33	P	I-protein
T22,T23	I-Entity,I-Entity	780	786	kappaB	kappaB	I-NP	NN	I-protein	30	NMOD	I-protein
T22	I-Entity	786	787	-	-	I-NP	HYPH	O	35	P	O
T22	I-Entity	787	796	dependent	dependent	I-NP	JJ	O	36	NMOD	O
T22	I-Entity	797	805	promoter	promoter	I-NP	NN	O	16	PMOD	O
O	O	805	806	.	.	O	.	O	1	P	O

O	O	807	809	In	In	B-PP	IN	O	19	VMOD	O
O	O	810	818	addition	addition	B-NP	NN	O	1	PMOD	O
O	O	818	819	,	,	O	,	O	19	P	O
O	O	820	821	a	a	B-NP	DT	O	18	NMOD	O
O	O	822	830	dominant	dominant	I-NP	JJ	B-DNA	18	NMOD	B-DNA
O	O	830	831	-	-	I-NP	HYPH	I-DNA	18	NMOD	I-DNA
O	O	831	839	negative	negative	I-NP	JJ	I-DNA	18	NMOD	I-DNA
O	O	840	846	mutant	mutant	I-NP	JJ	I-DNA	18	NMOD	I-DNA
T3	B-Protein	847	852	tumor	tumor	I-NP	NN	I-DNA	18	NMOD	I-DNA
T3	I-Protein	853	861	necrosis	necrosis	I-NP	NN	I-DNA	18	NMOD	I-DNA
T3	I-Protein	862	868	factor	factor	I-NP	NN	I-DNA	18	NMOD	I-DNA
T3	I-Protein	869	877	receptor	receptor	I-NP	NN	I-DNA	18	NMOD	I-DNA
T3	I-Protein	878	879	I	I	I-NP	CD	I-DNA	18	NMOD	I-DNA
O	O	880	881	(	(	O	(	I-DNA	18	NMOD	I-DNA
T4	B-Protein	881	886	TNFRI	TNFRI	B-NP	NN	I-DNA	18	NMOD	I-DNA
O	O	886	887	)	)	O	)	I-DNA	18	NMOD	I-DNA
O	O	888	898	expression	expression	B-NP	NN	I-DNA	18	NMOD	I-DNA
O	O	899	905	vector	vector	I-NP	NN	I-DNA	19	SUB	I-DNA
O	O	906	909	was	be	B-VP	VBD	O	0	ROOT	O
O	O	910	912	co	co	B-ADJP	AFX	O	19	PRD	O
O	O	912	913	-	-	B-NP	HYPH	O	20	P	O
O	O	913	924	transfected	transfecte	B-VP	VBN	O	20	DEP	O
O	O	925	927	in	in	B-PP	IN	O	22	VMOD	O
O	O	928	938	inhibition	inhibition	B-NP	NN	O	25	NMOD	O
O	O	939	946	studies	study	I-NP	NNS	O	23	PMOD	O
O	O	946	947	.	.	O	.	O	19	P	O

O	O	948	953	Forty	Forty	B-NP	CD	O	3	AMOD	O
O	O	953	954	-	-	I-NP	HYPH	O	3	P	O
O	O	954	959	eight	eight	I-NP	CD	O	4	NMOD	O
O	O	960	965	hours	hour	I-NP	NNS	O	5	PMOD	O
O	O	966	971	after	after	B-PP	IN	O	9	VMOD	O
O	O	972	984	transfection	transfection	B-NP	NN	O	5	PMOD	O
O	O	984	985	,	,	O	,	O	9	P	O
O	O	986	988	EC	EC	B-NP	NN	B-cell_type	9	SUB	B-cell_type
O	O	989	993	were	be	B-VP	VBD	O	0	ROOT	O
O	O	994	1004	stimulated	stimulate	I-VP	VBN	O	9	VC	O
O	O	1005	1009	with	with	B-PP	IN	O	10	VMOD	O
O	O	1010	1012	NK	NK	B-NP	NN	B-cell_type	13	NMOD	B-cell_type
O	O	1013	1018	cells	cell	I-NP	NNS	I-cell_type	18	NMOD	I-cell_type
O	O	1019	1021	or	or	O	CC	O	18	NMOD	O
O	O	1022	1024	NK	NK	B-NP	NN	B-cell_type	18	NMOD	B-cell_type
O	O	1025	1029	cell	cell	I-NP	NN	I-cell_type	18	NMOD	I-cell_type
O	O	1030	1038	membrane	membrane	I-NP	NN	I-cell_type	18	NMOD	I-cell_type
O	O	1039	1047	extracts	extract	I-NP	NNS	I-cell_type	11	PMOD	I-cell_type
O	O	1048	1051	for	for	B-PP	IN	O	10	VMOD	O
O	O	1052	1053	7	7	B-NP	CD	O	21	NMOD	O
O	O	1054	1056	hr	hr	I-NP	NN	O	23	NMOD	O
O	O	1057	1060	and	and	I-NP	CC	O	23	NMOD	O
O	O	1061	1071	activation	activation	I-NP	NN	O	19	PMOD	O
O	O	1072	1075	was	be	B-VP	VBD	O	9	VMOD	O
O	O	1076	1084	measured	measure	I-VP	VBN	O	24	VC	O
O	O	1085	1087	by	by	B-PP	IN	O	25	VMOD	O
O	O	1088	1089	a	a	B-NP	DT	O	29	NMOD	O
O	O	1090	1100	luciferase	luciferase	I-NP	NN	B-protein	29	NMOD	B-protein
O	O	1101	1106	assay	assay	I-NP	NN	O	26	PMOD	O
O	O	1106	1107	.	.	O	.	O	9	P	O

O	O	1108	1115	RESULTS	RESULTS	B-NP	NNS	O	12	SUB	O
O	O	1115	1116	:	:	O	:	O	1	P	O
O	O	1117	1119	Co	Co	O	AFX	B-DNA	12	VMOD	B-DNA
O	O	1119	1120	-	-	O	HYPH	O	12	P	O
O	O	1120	1127	culture	culture	B-NP	NN	O	12	SUB	O
O	O	1128	1130	of	of	B-PP	IN	O	5	NMOD	O
O	O	1131	1133	NK	NK	B-NP	NN	B-cell_type	8	NMOD	B-cell_type
O	O	1134	1139	cells	cell	I-NP	NNS	I-cell_type	6	PMOD	I-cell_type
O	O	1140	1144	with	with	B-PP	IN	O	5	NMOD	O
O	O	1145	1156	transfected	transfecte	B-NP	VBN	O	11	NMOD	O
O	O	1157	1159	EC	EC	I-NP	NN	B-cell_type	9	PMOD	B-cell_type
O	O	1160	1168	enhanced	enhance	B-VP	VBD	O	0	ROOT	O
T5	B-Protein	1169	1170	E	E	B-NP	NN	B-protein	15	NMOD	B-protein
T5	I-Protein	1170	1171	-	-	B-NP	HYPH	I-protein	15	NMOD	I-protein
T5	I-Protein	1171	1179	selectin	selectin	I-NP	NN	I-protein	28	NMOD	I-protein
O	O	1179	1180	,	,	O	,	O	18	P	O
T6	B-Protein	1181	1183	IL	IL	B-NP	NN	B-protein	18	NMOD	B-protein
T6	I-Protein	1183	1184	-	-	O	HYPH	I-protein	15	NMOD	I-protein
T6	I-Protein	1184	1185	8	8	B-NP	CD	I-protein	18	NMOD	I-protein
O	O	1185	1186	,	,	O	,	O	28	P	O
O	O	1187	1190	and	and	O	CC	O	28	NMOD	O
T24	B-Entity	1191	1193	NF	NF	B-NP	NN	B-protein	24	NMOD	B-protein
T24	I-Entity	1193	1194	-	-	B-NP	HYPH	I-protein	24	P	I-protein
T24	I-Entity	1194	1200	kappaB	kappaB	I-NP	NN	I-protein	28	NMOD	I-protein
O	O	1200	1201	-	-	I-NP	HYPH	O	28	NMOD	O
O	O	1201	1210	dependent	dependent	I-NP	JJ	O	28	NMOD	O
O	O	1211	1219	promoter	promoter	I-NP	NN	O	28	NMOD	O
O	O	1220	1228	activity	activity	I-NP	NN	O	12	OBJ	O
O	O	1228	1229	.	.	O	.	O	12	P	O

O	O	1230	1232	NK	NK	B-NP	NN	O	4	NMOD	O
O	O	1233	1237	cell	cell	I-NP	NN	O	4	NMOD	O
O	O	1238	1246	membrane	membrane	I-NP	NN	O	4	NMOD	O
O	O	1247	1255	extracts	extract	I-NP	NNS	O	5	SUB	O
O	O	1256	1264	retained	retain	B-VP	VBD	O	0	ROOT	O
O	O	1265	1268	the	the	B-NP	DT	O	7	NMOD	O
O	O	1269	1277	capacity	capacity	I-NP	NN	O	5	OBJ	O
O	O	1278	1280	to	to	B-VP	TO	O	9	VMOD	O
O	O	1281	1289	activate	activate	I-VP	VB	O	7	NMOD	O
O	O	1290	1292	EC	EC	B-NP	NN	B-cell_type	9	OBJ	B-cell_type
O	O	1293	1296	and	and	O	CC	O	5	VMOD	O
O	O	1297	1304	induced	induce	B-VP	VBD	O	5	VMOD	O
O	O	1305	1312	nuclear	nuclear	B-NP	JJ	O	14	NMOD	O
O	O	1313	1326	translocation	translocation	I-NP	NN	O	12	OBJ	O
O	O	1327	1329	of	of	B-PP	IN	O	14	NMOD	O
T25	B-Entity	1330	1332	NF	NF	B-NP	NN	B-protein	18	NMOD	B-protein
T25	I-Entity	1332	1333	-	-	O	HYPH	I-protein	18	NMOD	I-protein
T25	I-Entity	1333	1339	kappaB	kappaB	B-NP	NN	I-protein	15	PMOD	I-protein
O	O	1340	1341	(	(	O	(	O	23	DEP	O
T7	B-Protein	1341	1344	p50	p50	B-NP	NN	B-protein	22	NMOD	B-protein
O	O	1345	1348	and	and	O	CC	O	22	NMOD	O
T8	B-Protein	1349	1352	p65	p65	B-NP	NN	B-protein	23	DEP	B-protein
O	O	1352	1353	)	)	O	)	O	18	NMOD	O
O	O	1353	1354	.	.	O	.	O	5	P	O

O	O	1355	1362	Western	Western	B-NP	NN	O	2	NMOD	O
O	O	1363	1371	blotting	blotting	I-NP	NN	O	9	SUB	O
O	O	1372	1374	of	of	B-PP	IN	O	2	NMOD	O
O	O	1375	1377	NK	NK	B-NP	NN	B-cell_type	5	NMOD	B-cell_type
O	O	1378	1382	cell	cell	I-NP	NN	I-cell_type	8	NMOD	I-cell_type
O	O	1383	1386	and	and	I-NP	CC	O	8	NMOD	O
O	O	1387	1395	membrane	membrane	I-NP	NN	O	8	NMOD	O
O	O	1396	1404	extracts	extract	I-NP	NNS	O	3	PMOD	O
O	O	1405	1413	detected	detect	B-VP	VBD	O	0	ROOT	O
O	O	1414	1417	the	the	B-NP	DT	O	11	NMOD	O
O	O	1418	1426	presence	presence	I-NP	NN	O	9	OBJ	O
O	O	1427	1429	of	of	B-PP	IN	O	11	NMOD	O
T9	B-Protein	1430	1441	Lymphotoxin	Lymphotoxin	B-NP	NN	B-protein	15	NMOD	B-protein
T9	I-Protein	1441	1442	-	-	O	HYPH	I-protein	15	P	I-protein
T9	I-Protein	1442	1447	alpha	alpha	B-NP	SYM	I-protein	25	NMOD	I-protein
O	O	1448	1449	(	(	O	(	O	18	DEP	O
T10	B-Protein	1449	1456	LTalpha	LTalpha	B-NP	NN	B-protein	18	DEP	B-protein
O	O	1456	1457	)	)	O	)	O	15	AMOD	O
O	O	1458	1461	but	but	B-NP	CC	O	25	NMOD	O
O	O	1462	1465	not	not	I-NP	RB	O	19	DEP	O
T11	B-Protein	1466	1471	tumor	tumor	B-NP	NN	B-protein	25	NMOD	B-protein
T11	I-Protein	1472	1480	necrosis	necrosis	I-NP	NN	I-protein	25	NMOD	I-protein
T11	I-Protein	1481	1487	factor	factor	I-NP	NN	I-protein	25	NMOD	I-protein
T11	I-Protein	1487	1488	-	-	B-VP	HYPH	I-protein	25	P	I-protein
T11	I-Protein	1488	1493	alpha	alpha	B-NP	SYM	I-protein	12	PMOD	I-protein
O	O	1493	1494	.	.	O	.	O	9	P	O

O	O	1495	1506	Furthermore	Furthermore	B-ADVP	RB	O	4	VMOD	O
O	O	1506	1507	,	,	O	,	O	4	P	O
T12	B-Protein	1508	1515	LTalpha	LTalpha	B-NP	NN	B-protein	4	SUB	B-protein
O	O	1516	1519	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1520	1528	secreted	secrete	I-VP	VBN	O	4	VC	O
O	O	1529	1531	in	in	B-PP	IN	O	5	VMOD	O
O	O	1532	1534	NK	NK	B-NP	NN	O	6	PMOD	O
O	O	1534	1535	:	:	O	:	O	4	P	O
O	O	1535	1537	EC	EC	B-NP	NN	B-cell_type	12	NMOD	B-cell_type
O	O	1538	1540	co	co	B-NP	AFX	O	12	NMOD	O
O	O	1540	1541	-	-	I-NP	HYPH	B-cell_line	12	NMOD	B-cell_line
O	O	1541	1549	cultures	culture	B-NP	NNS	I-cell_line	4	VMOD	I-cell_line
O	O	1549	1550	.	.	O	.	O	4	P	O

O	O	1551	1553	Co	Co	B-NP	AFX	B-DNA	10	VMOD	B-DNA
O	O	1553	1554	-	-	I-NP	HYPH	O	10	P	O
O	O	1554	1566	transfection	transfection	B-NP	NN	O	10	SUB	O
O	O	1567	1571	with	with	B-PP	IN	O	3	NMOD	O
O	O	1572	1580	dominant	dominant	B-NP	JJ	B-protein	9	NMOD	B-protein
O	O	1580	1581	-	-	I-NP	HYPH	I-protein	9	NMOD	I-protein
O	O	1581	1589	negative	negative	I-NP	JJ	I-protein	9	NMOD	I-protein
O	O	1590	1596	mutant	mutant	I-NP	JJ	I-protein	9	NMOD	I-protein
T13	B-Protein	1597	1602	TNFRI	TNFRI	I-NP	NN	I-protein	4	PMOD	I-protein
O	O	1603	1612	inhibited	inhibit	B-VP	VBD	O	0	ROOT	O
O	O	1613	1615	EC	EC	B-NP	NN	B-cell_type	12	NMOD	B-cell_type
O	O	1616	1626	activation	activation	I-NP	NN	O	10	OBJ	O
O	O	1627	1629	by	by	B-PP	IN	O	12	NMOD	O
O	O	1630	1632	NK	NK	B-NP	NN	B-cell_type	17	NMOD	B-cell_type
O	O	1633	1637	cell	cell	I-NP	NN	I-cell_type	17	NMOD	I-cell_type
O	O	1638	1646	membrane	membrane	I-NP	NN	O	17	NMOD	O
O	O	1647	1655	extracts	extract	I-NP	NNS	O	13	PMOD	O
O	O	1656	1659	and	and	B-PP	CC	O	13	PMOD	O
O	O	1660	1662	by	by	B-PP	IN	O	13	PMOD	O
O	O	1663	1665	NK	NK	B-NP	NN	B-cell_type	21	NMOD	B-cell_type
O	O	1666	1671	cells	cell	I-NP	NNS	I-cell_type	19	PMOD	I-cell_type
O	O	1672	1674	by	by	B-PP	IN	O	10	VMOD	O
O	O	1675	1677	80	80	B-NP	CD	O	24	NMOD	O
O	O	1677	1678	%	%	I-NP	NN	O	27	NMOD	O
O	O	1679	1682	and	and	O	CC	O	27	NMOD	O
O	O	1683	1685	47	47	B-NP	CD	O	27	NMOD	O
O	O	1685	1686	%	%	I-NP	NN	O	22	PMOD	O
O	O	1686	1687	,	,	O	,	O	10	P	O
O	O	1688	1700	respectively	respectively	B-ADVP	RB	O	10	VMOD	O
O	O	1700	1701	.	.	O	.	O	10	P	O

O	O	1702	1705	The	The	B-NP	DT	O	3	NMOD	O
O	O	1706	1710	same	same	I-NP	JJ	O	3	NMOD	O
O	O	1711	1718	pattern	pattern	I-NP	NN	O	6	SUB	O
O	O	1719	1721	of	of	B-PP	IN	O	3	NMOD	O
O	O	1722	1732	inhibition	inhibition	B-NP	NN	O	4	PMOD	O
O	O	1733	1736	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1737	1745	observed	observe	I-VP	VBN	O	6	VC	O
O	O	1746	1751	using	use	B-VP	VBG	O	6	VMOD	O
O	O	1752	1756	anti	anti	B-NP	AFX	O	13	NMOD	O
O	O	1756	1757	-	-	I-NP	HYPH	O	13	P	O
O	O	1757	1762	human	human	I-NP	JJ	O	13	NMOD	O
O	O	1763	1765	LT	LT	I-NP	NN	O	13	NMOD	O
O	O	1766	1770	sera	serum	I-NP	NNS	O	8	OBJ	O
O	O	1770	1771	.	.	O	.	O	6	P	O

O	O	1772	1783	CONCLUSIONS	CONCLUSIONS	B-NP	NNS	O	0	ROOT	O
O	O	1783	1784	:	:	O	:	O	1	P	O
O	O	1785	1790	Human	Human	B-NP	JJ	O	6	NMOD	O
O	O	1791	1793	NK	NK	I-NP	NN	O	6	NMOD	O
O	O	1794	1798	cell	cell	I-NP	NN	O	6	NMOD	O
O	O	1799	1807	membrane	membrane	I-NP	NN	O	1	NMOD	O
O	O	1807	1808	-	-	B-VP	HYPH	O	6	NMOD	O
O	O	1808	1813	bound	bind	B-NP	VBN	O	7	VC	O
O	O	1814	1816	LT	LT	I-NP	NN	B-protein	10	NMOD	B-protein
O	O	1817	1824	signals	signal	I-NP	NNS	I-protein	8	PMOD	I-protein
O	O	1825	1831	across	across	B-PP	IN	I-protein	10	NMOD	I-protein
O	O	1832	1839	species	specie	B-NP	NNS	I-protein	11	PMOD	I-protein
O	O	1840	1843	via	via	B-PP	IN	O	8	VMOD	O
T14	B-Protein	1844	1849	TNFRI	TNFRI	B-NP	NN	B-protein	13	PMOD	B-protein
O	O	1849	1850	,	,	O	,	O	6	P	O
O	O	1851	1858	leading	lead	B-VP	VBG	O	6	NMOD	O
O	O	1859	1861	to	to	B-PP	TO	O	16	VMOD	O
T26	B-Entity	1862	1864	NF	NF	B-NP	NN	B-protein	22	NMOD	B-protein
T26	I-Entity	1864	1865	-	-	I-NP	HYPH	I-protein	22	NMOD	I-protein
T26	I-Entity	1865	1871	kappaB	kappaB	I-NP	NN	I-protein	22	NMOD	I-protein
O	O	1872	1879	nuclear	nuclear	I-NP	JJ	O	22	NMOD	O
O	O	1880	1893	translocation	translocation	I-NP	NN	O	24	NMOD	O
O	O	1894	1897	and	and	I-NP	CC	O	24	NMOD	O
O	O	1898	1911	transcription	transcription	I-NP	NN	O	17	PMOD	O
O	O	1912	1914	of	of	B-PP	IN	O	24	NMOD	O
T15	B-Protein	1915	1916	E	E	B-NP	NN	B-protein	28	NMOD	B-protein
T15	I-Protein	1916	1917	-	-	B-NP	HYPH	I-protein	28	NMOD	I-protein
T15	I-Protein	1917	1925	selectin	selectin	I-NP	NN	I-protein	31	NMOD	I-protein
O	O	1926	1929	and	and	I-NP	CC	O	31	NMOD	O
T16	B-Protein	1930	1932	IL	IL	I-NP	NN	B-protein	31	NMOD	B-protein
T16	I-Protein	1932	1933	-	-	B-NP	HYPH	I-protein	25	PMOD	I-protein
T16	I-Protein	1933	1934	8	8	I-NP	CD	I-protein	31	NMOD	I-protein
O	O	1934	1935	,	,	O	,	O	31	P	O
O	O	1936	1941	which	which	B-NP	WDT	O	31	NMOD	O
O	O	1942	1949	results	result	B-VP	VBZ	O	34	SBAR	O
O	O	1950	1952	in	in	B-PP	IN	O	35	VMOD	O
O	O	1953	1955	EC	EC	B-NP	NN	B-cell_type	38	NMOD	B-cell_type
O	O	1956	1966	activation	activation	I-NP	NN	O	36	PMOD	O
O	O	1966	1967	.	.	O	.	O	1	P	O

O	O	1968	1971	The	The	B-NP	DT	O	2	NMOD	O
O	O	1972	1983	discrepancy	discrepancy	I-NP	NN	O	17	SUB	O
O	O	1984	1986	in	in	B-PP	IN	O	2	NMOD	O
O	O	1987	1990	the	the	B-NP	DT	O	5	NMOD	O
O	O	1991	1997	degree	degree	I-NP	NN	O	3	PMOD	O
O	O	1998	2000	of	of	B-PP	IN	O	5	NMOD	O
O	O	2001	2011	inhibition	inhibition	B-NP	NN	O	6	PMOD	O
O	O	2012	2014	by	by	B-PP	IN	O	5	NMOD	O
O	O	2015	2023	membrane	membrane	B-NP	NN	O	10	NMOD	O
O	O	2024	2032	extracts	extract	I-NP	NNS	O	13	NMOD	O
O	O	2033	2036	and	and	O	CC	O	13	NMOD	O
O	O	2037	2039	NK	NK	B-NP	NN	B-cell_type	13	NMOD	B-cell_type
O	O	2040	2045	cells	cell	I-NP	NNS	I-cell_type	8	PMOD	I-cell_type
O	O	2046	2050	with	with	B-PP	IN	O	5	NMOD	O
O	O	2051	2057	mutant	mutant	B-NP	JJ	B-protein	16	NMOD	B-protein
T17	B-Protein	2058	2063	TNFRI	TNFRI	I-NP	NN	I-protein	14	PMOD	I-protein
O	O	2064	2072	suggests	suggest	B-VP	VBZ	O	0	ROOT	O
O	O	2073	2077	that	that	B-SBAR	IN	O	17	VMOD	O
O	O	2078	2088	additional	additional	B-NP	JJ	O	20	NMOD	O
O	O	2089	2097	pathways	pathway	I-NP	NNS	O	21	SUB	O
O	O	2098	2101	are	be	B-VP	VBP	O	18	SBAR	O
O	O	2102	2110	utilized	utilize	I-VP	VBN	O	21	VC	O
O	O	2111	2113	by	by	B-PP	IN	O	22	VMOD	O
O	O	2114	2116	NK	NK	B-NP	NN	B-cell_type	25	NMOD	B-cell_type
O	O	2117	2122	cells	cell	I-NP	NNS	I-cell_type	23	PMOD	I-cell_type
O	O	2123	2125	to	to	B-VP	TO	O	27	VMOD	O
O	O	2126	2134	activate	activate	I-VP	VB	O	21	VMOD	O
O	O	2135	2137	EC	EC	B-NP	NN	B-cell_type	27	OBJ	B-cell_type
O	O	2137	2138	.	.	O	.	O	17	P	O
